ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04512	ECM-receptor interaction	12/157	79/7206	1.09135622798e-07
ko04060	Cytokine-cytokine receptor interaction	17/157	191/7206	7.3220149755e-07
ko04668	TNF signaling pathway	13/157	120/7206	1.77437239475e-06
ko04974	Protein digestion and absorption	11/157	96/7206	6.61745570553e-06
ko04510	Focal adhesion	16/157	240/7206	6.20351103087e-05
ko05164	Influenza A	13/157	167/7206	6.54420761393e-05
ko05160	Hepatitis C	11/157	153/7206	0.000481638338498
ko04621	NOD-like receptor signaling pathway	11/157	157/7206	0.000599431532676
ko00350	Tyrosine metabolism	5/157	33/7206	0.000667527504069
ko04920	Adipocytokine signaling pathway	8/157	89/7206	0.000672631158725
ko04658	Th1 and Th2 cell differentiation	8/157	96/7206	0.00111074140061
ko05161	Hepatitis B	11/157	173/7206	0.00133783576422
ko05146	Amoebiasis	8/157	99/7206	0.00135738312875
ko00643	Styrene degradation	2/157	4/7206	0.00274984962112
ko04657	IL-17 signaling pathway	7/157	87/7206	0.00276910786997
ko04931	Insulin resistance	9/157	137/7206	0.00292797737099
ko05222	Small cell lung cancer	7/157	89/7206	0.00314932625847
ko05145	Toxoplasmosis	8/157	126/7206	0.0060815710467
ko04932	Non-alcoholic fatty liver disease (NAFLD)	10/157	182/7206	0.00626279177158
ko04630	Jak-STAT signaling pathway	8/157	132/7206	0.00799466156546
ko05205	Proteoglycans in cancer	13/157	271/7206	0.00834409590396
ko04623	Cytosolic DNA-sensing pathway	4/157	41/7206	0.011741071033
ko05168	Herpes simplex infection	9/157	182/7206	0.0176885074425
ko04064	NF-kappa B signaling pathway	6/157	96/7206	0.0180321233365
ko01522	Endocrine resistance	7/157	124/7206	0.018343516152
ko05132	Salmonella infection	6/157	98/7206	0.0197670697178
ko05219	Bladder cancer	4/157	48/7206	0.0200731825921
ko04620	Toll-like receptor signaling pathway	6/157	100/7206	0.0216125961721
ko00401	Novobiocin biosynthesis	1/157	1/7206	0.0217873993894
ko05134	Legionellosis	5/157	74/7206	0.0222350930445
ko04115	p53 signaling pathway	5/157	74/7206	0.0222350930445
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2/157	11/7206	0.0228024252115
ko05142	Chagas disease (American trypanosomiasis)	7/157	130/7206	0.0231279266451
ko04380	Osteoclast differentiation	7/157	134/7206	0.0267595529664
ko04933	AGE-RAGE signaling pathway in diabetic complications	7/157	135/7206	0.0277249807716
ko04151	PI3K-Akt signaling pathway	15/157	390/7206	0.030070936816
ko05131	Shigellosis	5/157	82/7206	0.0328389633099
ko05321	Inflammatory bowel disease (IBD)	4/157	56/7206	0.0331825359721
ko00760	Nicotinate and nicotinamide metabolism	3/157	34/7206	0.0370825414804
ko05133	Pertussis	5/157	87/7206	0.0408337745974
ko00254	Aflatoxin biosynthesis	1/157	2/7206	0.0431030660511
ko05323	Rheumatoid arthritis	5/157	89/7206	0.044334858429
ko04330	Notch signaling pathway	4/157	62/7206	0.0456502436019
ko04622	RIG-I-like receptor signaling pathway	4/157	62/7206	0.0456502436019
ko04672	Intestinal immune network for IgA production	3/157	37/7206	0.0459460650693
ko05162	Measles	6/157	120/7206	0.0466875033206